Q2 2026 Amarin Corporation PLC Earnings Call Transcript

Jul 29, 2026 / 12:00 PM GMT

Release Date Price: €11.9

Transcript 10-Q8-K

Key Points

Positve

Amarin Corp PLC (AMRN) has successfully implemented a dual commercial strategy, combining U.S. business execution with an international commercial platform, resulting in a scalable business model.
VASCEPA is commercially available in 22 countries, with significant growth in international markets, particularly in Europe under the Recordati partnership.
The company has completed restructuring activities, resulting in a significantly lower cost base and enhanced ability to execute long-term growth strategies.
Amarin Corp PLC (AMRN) reported positive cash flow for the third consecutive quarter, improving its cash position by $12 million from year-end 2025.
The U.S. business remains profitable despite ongoing generic pressure, with VASCEPA retaining a leading position in the icosapent ethyl market.

Negative

Total net revenue in Q2 2026 was $42.2 million, a decrease from $72.7 million in the same quarter last year, partly due to a $25 million upfront payment in 2025.
U.S. product revenue declined to $32.2 million from $36.5 million in Q2 2025, driven by ongoing pricing pressure in the competitive generic market.
European product revenue was $5.4 million, down from $6.6 million in Q2 2025, reflecting the transition to the Recordati partnership.
Cost of goods sold in Q2 2026 rose by 22% to $27.2 million, primarily due to increased product volumes associated with regaining an exclusive PBM relationship in the U.S.
The company reported an operating loss of $12 million in Q2 2026, although this was an improvement from a $16 million loss in the same period last year.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

AMRN.OQ - Amarin Corporation PLC
Q2 2026 Amarin Corporation PLC Earnings Call
Jul 29, 2026 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning and welcome to Ameren Corporation's conference call to discuss its second-quarter 2026 financial results.

At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press *0 on your telephone keypad. Please note this conference is being recorded. I would now like to turn the conference call over to Devin Sullivan, Investor Relations for Ameren.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you for your time

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.